GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Beginning Cash Position

Medy-Tox (XKRX:086900) Beginning Cash Position : ₩33,246 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Beginning Cash Position?

Medy-Tox's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩33,246 Mil.

Medy-Tox's quarterly Beginning Cash Position declined from Sep. 2023 (₩49,014 Mil) to Dec. 2023 (₩40,284 Mil) and declined from Dec. 2023 (₩40,284 Mil) to Mar. 2024 (₩33,246 Mil).

Medy-Tox's annual Beginning Cash Position increased from Dec. 2021 (₩43,993 Mil) to Dec. 2022 (₩71,777 Mil) but then declined from Dec. 2022 (₩71,777 Mil) to Dec. 2023 (₩20,688 Mil).


Medy-Tox Beginning Cash Position Historical Data

The historical data trend for Medy-Tox's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Beginning Cash Position Chart

Medy-Tox Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19,247.42 20,016.78 43,993.40 71,777.11 20,688.10

Medy-Tox Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,688.10 41,185.25 49,014.16 40,284.12 33,246.22

Medy-Tox Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Medy-Tox Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Medy-Tox (XKRX:086900) Business Description

Traded in Other Exchanges
N/A
Address
641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines